Warning: Missing argument 2 for wp_kses(), called in /home/sites/manentia.co.uk/public_html/wp-content/themes/Make/framework/includes/rs-frontend-functions.php on line 149 and defined in /home/sites/manentia.co.uk/public_html/wp-includes/kses.php on line 713 Notice: Undefined variable: allowed_html in /home/sites/manentia.co.uk/public_html/wp-includes/kses.php on line 720 Notice: Undefined variable: allowed_html in /home/sites/manentia.co.uk/public_html/wp-includes/kses.php on line 722 Author: David Fleet

About Time!

It’s about time the government (NICE) tightened up on Pharma pricing of drugs! >>LINK<<

Read More

Merck To Work With Amazon (AWS) To Use Alexa In Chronic Disease

Really! Pharma intends to get voice enabled computers to remind patients about nutrition plans and dosing at least initially in Type II diabetes >>> <<LINK>>

Read More

Vitrification Or Organ Freezing

Freezing organs for donors is fine The problem comes when trying to reheat them for use! Using silica-coated iron oxide nanoparticles as part of the freezing process is a very neat way of solving the warming problem and helping organs to last longer in the deep freeze >>> <<LINK>> 

Read More

Wearables In Clinical Trials!

Takeda using the iWatch to collect ‘real life’ data from Parkinson’s patients Including continuous vitals monitoring with prompted cognition and mood data in ePRO form >>> http://www.fiercepharma.com/marketing/takeda-partners-cognition-kit-wearable-study-for-depression?utm_medium=nl&utm_source=internal&mrkid=938224&mkt_tok=eyJpIjoiWXpka05qVTBaRGxrWm1abCIsInQiOiJpSmVueXM1RDBYRHRGVklGeVBscThBYzRFVG1uZGgrT2F3UXBycjR3ZmFKSHJLeVA5QWJGbFo0WUFNQzZyenJKVzJhZ3lOdXIwK1ppXC9yNnZJYXV2MDkrenJqM0g0d1E2blBvS0ZDeTlXUkc3ZjJDS2gwd3k2RVRCcmczMFFMRXMifQ%3D%3D

Read More

Personalised Adverse Events!

Another use for stem cell technology I did talk to Aidan Courtney at Censobio.com who expects to do a similar thing – predicting response to AD treatment with stem cell testing>>> http://newatlas.com/stem-cells-personalized-testing-cancer-drug/48178/?utm_source=Gizmag+Subscribers&utm_campaign=08c7982cf2-UA-2235360-4&utm_medium=email&utm_term=0_65b67362bd-08c7982cf2-91677545

Read More

AD Another Phase III Trial- Roche/Genentech

AC Immune’s crenezumab already has one Phase III trial in progress now they’ve started another. All based on their ‘failed’ Phase II study. Where’s the sense – or is it just me >> http://www.fiercebiotech.com/r-d/roche-starts-second-alzheimer-s-phase-3-anti-abeta-drug?utm_medium=nl&utm_source=internal&mrkid=938224&mkt_tok=eyJpIjoiTkdJMFpUZzFaakkwTmpBeCIsInQiOiJoVWxqQ2tsbFVjSjlWSThTK3pZM2lHTFY0TTI3NGVSamFqUjRINnVCdzlZdkM0S0RwODBzU0hleTZmckg4QjcyaEFwSVhSOHd3XC9xUnZ5TWNGTzZweWordllsZU9EZ2pOVWVSSHRLNnJqTWpEekl4eWkweHpEejN2Y2xEcTlVYzIifQ%3D%3D

Read More

AD Another Phase III Failure – Accera

Did they really think this was going to work in the first place A triglyceride and a re-formulation with less bioavailability post Phase II Who funds these ideas! >> More Phase 3 disappointment in Alzheimer’s disease  

Read More

MHRA To Develop FDA Links

Apparently the MHRA is may consider developing links with the FDA post Brexit now the the EMA will move out of London The aim would be to have agreement in place to allow fast track approvals. Now that would be interesting >>>   http://www.thetimes.co.uk/edition/business/britain-eyes-american-drug-approval-pact-0mwrj7g6f

Read More

Microsoft Getting Into Healthcare?

Looks like they want to use NExT to interrogate medical records in a big way>>>> Microsoft refocuses in healthcare, teams with UPMC on innovation

Read More

Taking Mobile Tech One Step Too Far?

How about Transhumanism for the ultimate connection to technology >> http://newatlas.com/transhumanism-mainstream-era-popular/47941/?utm_source=Gizmag+Subscribers&utm_campaign=451d4e2031-UA-2235360-4&utm_medium=email&utm_term=0_65b67362bd-451d4e2031-91677545

Read More